Abstract
ObjectiveTo compare the NK-1 receptor antagonist maropitant to morphine during and after surgery in dogs undergoing ovariohysterectomy (OHE).Methods30 healthy female dogs were randomly divided to receive either a pre-anaesthetic dose of morphine (0.5 mg/kg SQ) or maropitant (1 mg/kg, SQ) prior to OHE. Anaesthesia was induced with propofol and maintained with isoflurane. Expired isoflurane concentration, heart rate (HR), systolic arterial pressure (SAP) and respiratory rate were measured. Post-operative pain scores and appetite were evaluated during the recovery period. Rescue analgesia (morphine 0.1 mg/kg IV) was administered as needed post-operatively based on blinded pain score assessments.ResultsAlthough clinically comparable; during surgical stimulation, the maropitant group had lower HR (108±18 vs 115±24 bpm; p = 0.04), lower SAP (114±23 vs 125±23 mmHg; p = 0.003) and required slightly lower percent of isoflurane anaesthetic (1.35±0.2 vs 1.51±0.4%; p = 0.005), when compared to the morphine group. In the recovery period, the maropitant group had lower pain scores at extubation (1.7±0.7 vs 3.4±2.3; p = 0.0001) and were more likely to eat within 3 hours after extubation (64.7 vs 15.3%). However, post-operative rescue analgesia requirements were similar between groups. All other measured parameters were similar between groups. The overall difference observed between groups was small and all monitored and measured parameters were within the expected range for anesthetized dogs.Clinical SignificanceNo major differences in cardiorespiratory parameters or anaesthetic requirements were observed between maropitant and morphine when used as a pre-anesthetic agent for OHE. Further studies are necessary to fully elucidate the benefits of maropitant as a pre-anaesthetic agent for canine OHE.
Highlights
Substance P is a neuropeptide that activates nociceptive pathways associated with pain perception
Dogs in the maropitant group were more likely to eat during the first 180 minute of recovery period when compared to the morphine group
Fewer dogs were entered into the morphine group (13 compared to 17 in the maropitant group)
Summary
Substance P is a neuropeptide that activates nociceptive pathways associated with pain perception. Substance P activation of pain pathways is mediated through neurokinin 1 (NK-1) receptors. Research using NK-1 receptor antagonists to block nociceptive pathways suggest that NK-1 antagonists may be effective when managing visceral pain in a number of animal studies [1,2,3,4,5,6]. In clinical human trials NK-1 antagonist drugs used to manage and treat nociception or pain, especially somatic pain, have been disappointing [7,8]. A potential difference may result from the relative density of NK-1 receptors or the amount of substance P released in somatic or visceral afferent pathways [9]
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have